This study aims to identify novel inflammatory biomarkers in AC, whether in circulating blood, in situ or as imaging biomarkers to better understand the pathophysiology of the disease and then to determine contribution to the clinical management of patients.
Adult patient (age ≥ 18 years old)
Patient with a probable or confirmed diagnosis of cardiomyopathy according to the diagnostic criteria of the international task force
Patient carrying a pathogenic mutation responsible for cardiomyopathy
Patient informed individually of the research
Patients under curatorship/guardianship
Pregnant women
Patients who expressed their opposition to participate in the study